The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for hemin (Recordati Rare Diseases Australia Pty Ltd)
Active ingredients
hemin
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection
Indication
For the treatment of acute attacks of hepatic porphyria (acute intermittent porphyria, porphyria variegata, hereditary corproporphyria and delta-aminolevulinic acid dehydratase porphyria)
Therapeutic area
Haematology